Trybe Capital Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-94,519
| Closed | -$7.03M | – | 11 |
|
|
2023
Q2 | $7.03M | Buy |
94,519
+68,160
| +259% | +$5.07M | 2.43% | 11 |
|
|
2023
Q1 | $1.4M | Buy |
+26,359
| New | +$1.4M | 0.77% | 9 |
|
|
2022
Q4 | – | Sell |
-26,359
| Closed | -$3.29M | – | 10 |
|
|
2022
Q3 | $3.29M | Hold |
26,359
| – | – | 2.23% | 10 |
|
|
2022
Q2 | $2.51M | Sell |
26,359
-3,841
| -13% | -$366K | 2.06% | 10 |
|
|
2022
Q1 | $4.87M | Hold |
30,200
| – | – | 2.03% | 10 |
|
|
2021
Q4 | $10M | Hold |
30,200
| – | – | 4.11% | 10 |
|
|
2021
Q3 | $14M | Buy |
+30,200
| New | +$14M | 7.97% | 7 |
|